Crispr Having Or Associated With Destabilization Domains - EP3237615

The patent EP3237615 was granted to Massachusetts Institute OF Technology on Jul 26, 2023. The application was originally filed on Dec 21, 2015 under application number EP15831022A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3237615

MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Application Number
EP15831022A
Filing Date
Dec 21, 2015
Status
Patent Maintained As Amended
Jun 23, 2023
Publication Date
Jul 26, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

PATENT BOUTIQUENov 12, 2020PATENT BOUTIQUEADMISSIBLE
JAMES POOLENov 11, 2020CARPMAELS & RANSFORDADMISSIBLE

Patent Citations (207) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS20040491026
DESCRIPTIONUS20070953797
DESCRIPTIONUS20090511940
DESCRIPTIONWO1994US05700
DESCRIPTIONWO2007US84654
DESCRIPTIONWO2014US41806
DESCRIPTIONWO2014US62558
DESCRIPTIONWO2014US69925
DESCRIPTIONWO2015US45504
DESCRIPTIONWO2015US51691
DESCRIPTIONWO2015US51830
DESCRIPTIONEP0264166
DESCRIPTIONEP1519714
DESCRIPTIONEP1664316
DESCRIPTIONEP1766035
DESCRIPTIONEP1781593
DESCRIPTIONEP2764103
DESCRIPTIONEP2771468
DESCRIPTIONEP2784162
DESCRIPTIONUS2003087817
DESCRIPTIONUS2004013648
DESCRIPTIONUS2004171156
DESCRIPTIONUS2005019923
DESCRIPTIONUS2005287127
DESCRIPTIONUS2006030837
DESCRIPTIONUS2006281180
DESCRIPTIONUS2007025970
DESCRIPTIONUS2007054961
DESCRIPTIONUS2007093878
DESCRIPTIONUS2008267903
DESCRIPTIONUS2009007284
DESCRIPTIONUS2009017543
DESCRIPTIONUS2009100536
DESCRIPTIONUS2009111106
DESCRIPTIONUS2009222937
DESCRIPTIONUS2009271881
DESCRIPTIONUS2010229252
DESCRIPTIONUS2010311124
DESCRIPTIONUS2010317109
DESCRIPTIONUS2011023139
DESCRIPTIONUS2011059502
DESCRIPTIONUS2011091441
DESCRIPTIONUS2011117189
DESCRIPTIONUS2011142917
DESCRIPTIONUS2011158957
DESCRIPTIONUS2011182867
DESCRIPTIONUS2011195123
DESCRIPTIONUS2011225664
DESCRIPTIONUS2011265198
DESCRIPTIONUS2011293571
DESCRIPTIONUS2011293703
DESCRIPTIONUS2012017290
DESCRIPTIONUS2012159653
DESCRIPTIONUS2012204282
DESCRIPTIONUS2012251560
DESCRIPTIONUS2012251618
DESCRIPTIONUS2012295960
DESCRIPTIONUS2012328580
DESCRIPTIONUS2013145487
DESCRIPTIONUS2013183282
DESCRIPTIONUS2013202678
DESCRIPTIONUS2013236946
DESCRIPTIONUS2013244279
DESCRIPTIONUS2013245107
DESCRIPTIONUS2013252281
DESCRIPTIONUS2013253040
DESCRIPTIONUS2013302401
DESCRIPTIONUS2014170753
DESCRIPTIONUS2014179006
DESCRIPTIONUS2014179770
DESCRIPTIONUS2014186843
DESCRIPTIONUS2014186919
DESCRIPTIONUS2014186958
DESCRIPTIONUS2014189896
DESCRIPTIONUS2014227787
DESCRIPTIONUS2014234972
DESCRIPTIONUS2014242664
DESCRIPTIONUS2014242699
DESCRIPTIONUS2014242700
DESCRIPTIONUS2014248702
DESCRIPTIONUS2014256046
DESCRIPTIONUS2014273231
DESCRIPTIONUS2014273232
DESCRIPTIONUS2014273234
DESCRIPTIONUS2014287938
DESCRIPTIONUS2014310830
DESCRIPTIONUS2014357530
DESCRIPTIONUS2015184139
DESCRIPTIONUS2015232881
DESCRIPTIONUS4186183
DESCRIPTIONUS4217344
DESCRIPTIONUS4235871
DESCRIPTIONUS4261975
DESCRIPTIONUS4485054
DESCRIPTIONUS4501728
DESCRIPTIONUS4774085
DESCRIPTIONUS4797368
DESCRIPTIONUS4837028
DESCRIPTIONUS4873316
DESCRIPTIONUS4897355
DESCRIPTIONUS4946787
DESCRIPTIONUS5049386
DESCRIPTIONUS5173414
DESCRIPTIONUS5210015
DESCRIPTIONUS5445934
DESCRIPTIONUS5543158
DESCRIPTIONUS5580859
DESCRIPTIONUS5589466
DESCRIPTIONUS5593972
DESCRIPTIONUS5846946
DESCRIPTIONUS5855913
DESCRIPTIONUS5985309
DESCRIPTIONUS6007845
DESCRIPTIONUS6603061
DESCRIPTIONUS6750059
DESCRIPTIONUS7206639
DESCRIPTIONUS7259015
DESCRIPTIONUS7303910
DESCRIPTIONUS7351585
DESCRIPTIONUS7745651
DESCRIPTIONUS7776321
DESCRIPTIONUS7799565
DESCRIPTIONUS7803397
DESCRIPTIONUS7838658
DESCRIPTIONUS7868149
DESCRIPTIONUS7901708
DESCRIPTIONUS7915399
DESCRIPTIONUS7982027
DESCRIPTIONUS8058069
DESCRIPTIONUS8101741
DESCRIPTIONUS8188263
DESCRIPTIONUS8236943
DESCRIPTIONUS8283333
DESCRIPTIONUS8372951
DESCRIPTIONUS8404658
DESCRIPTIONUS8454972
DESCRIPTIONUS8507272
DESCRIPTIONUS8575305
DESCRIPTIONUS8642295
DESCRIPTIONUS8697359
DESCRIPTIONUS8709843
DESCRIPTIONUS8771945
DESCRIPTIONUS8795965
DESCRIPTIONUS8865406
DESCRIPTIONUS8871445
DESCRIPTIONUS8889356
DESCRIPTIONUS8889418
DESCRIPTIONUS8895308
DESCRIPTIONUS8906616
DESCRIPTIONUS8932814
DESCRIPTIONUS8945839
DESCRIPTIONUS8993233
DESCRIPTIONUS8999641
DESCRIPTIONWO2011028929
DESCRIPTIONWO2012135025
DESCRIPTIONWO2013126794
DESCRIPTIONWO2013163628
DESCRIPTIONWO2014018423
DESCRIPTIONWO2014093595
DESCRIPTIONWO2014093622
DESCRIPTIONWO2014093635
DESCRIPTIONWO2014093655
DESCRIPTIONWO2014093661
DESCRIPTIONWO2014093694
DESCRIPTIONWO2014093701
DESCRIPTIONWO2014093709
DESCRIPTIONWO2014093712
DESCRIPTIONWO2014093718
DESCRIPTIONWO2014204723
DESCRIPTIONWO2014204724
DESCRIPTIONWO2014204725
DESCRIPTIONWO2014204726
DESCRIPTIONWO2014204727
DESCRIPTIONWO2014204728
DESCRIPTIONWO2014204729
DESCRIPTIONWO2015048577
DESCRIPTIONWO2015070083
DESCRIPTIONWO2015089351
DESCRIPTIONWO2015089354
DESCRIPTIONWO2015089364
DESCRIPTIONWO2015089419
DESCRIPTIONWO2015089427
DESCRIPTIONWO2015089462
DESCRIPTIONWO2015089465
DESCRIPTIONWO2015089473
DESCRIPTIONWO2015089486
DESCRIPTIONWO2015105928
DESCRIPTIONWO2015134812
DESCRIPTIONWO2015138510
DESCRIPTIONWO2015148670
DESCRIPTIONWO2015148860
DESCRIPTIONWO2015148863
DESCRIPTIONWO2015153780
DESCRIPTIONWO2015153789
DESCRIPTIONWO2015153791
DESCRIPTIONWO2015161276
DESCRIPTIONWO9116024
DESCRIPTIONWO9117424
DESCRIPTIONWO9324641
DESCRIPTIONWO9639154
DESCRIPTIONWO9703211
INTERNATIONAL-SEARCH-REPORTWO2014093622
INTERNATIONAL-SEARCH-REPORTWO2015070083
INTERNATIONAL-SEARCH-REPORTWO2015089351
INTERNATIONAL-SEARCH-REPORTWO2015089427
OPPOSITIONWO2013176772
OPPOSITIONWO2015089427

Non-Patent Literature (NPL) Citations (391) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ADVANCED DRUG DELIVERY REVIEWS, (2012), vol. 64, pages 1730 - 1737
DESCRIPTION- AHMAD ET AL., CANCER RES., (1992), vol. 52, pages 4817 - 4820
DESCRIPTION- AHMAD, S. ET AL., J ROYAL SOC INTERFACE, (2010), vol. 7, pages 423 - 33
DESCRIPTION- AIUTI ET AL., NAT. MED., (2002), vol. 8, pages 423 - 425
DESCRIPTION- AKINC ET AL., NAT. BIOTECH., (2010), vol. 26, pages 561 - 569
DESCRIPTION- ALABI ET AL., PROC NATL ACAD SCI USA., (20130806), vol. 110, no. 32, pages 12881 - 6
DESCRIPTION- ALTSCHUL ET AL., J. MOL. BIOL., (1990), pages 403 - 410
DESCRIPTION- ALVAREZ-ERVITI ET AL., NAT BIOTECHNOL, (2011), vol. 29, page 341
DESCRIPTION- AMRANN ET AL., GENE, (1988), vol. 69, pages 301 - 315
DESCRIPTION- ANDERSON, SCIENCE, (1992), vol. 256, pages 808 - 813
DESCRIPTION- A.R. GRUBER ET AL., CELL, (2008), vol. 106, no. 1, pages 23 - 24
DESCRIPTION- ATSCHUL ET AL., J. MOL. BIOL., (1990), pages 403 - 410
DESCRIPTION- AUSUBEL ET AL., SHORT PROTOCOLS IN MOLECULAR BIOLOGY, (1999), pages 7 - 58,7-60
DESCRIPTION- BALAGAAN, J GENE MED, (2006), vol. 8, pages 275 - 285
DESCRIPTION- BALAGAAN, J Gene Med, WILEY INTERSCIENCE, (20051121), vol. 8, pages 275 - 285
DESCRIPTION- BALDARI ET AL., EMBO J., (1987), vol. 6, pages 229 - 234
DESCRIPTION- BANASZYNSKI LA; SELLMYER MA; CONTAG CH; WANDLESS TJ; THORNE SH, "Chemical control of protein stability and function in living mice", NAT MED, (2008), vol. 14, pages 1123 - 1127
DESCRIPTION- BANEIJI ET AL., CELL, (1983), vol. 33, pages 729 - 740
DESCRIPTION- BARTLETT ET AL., PNAS, (20070925), vol. 104, no. 39
DESCRIPTION- BAUER ET AL., SCIENCE, (20131011), vol. 342, no. 6155, pages 253 - 257
DESCRIPTION- BEHR ET AL., BIOCONJUGATE CHEM, (1994), vol. 5, pages 382 - 389
DESCRIPTION- BELHAJ ET AL., PLANT METHODS, vol. 9, page 39
DESCRIPTION- BINLEY ET AL., HUMAN GENE THERAPY, (201209), vol. 23, pages 980 - 991
DESCRIPTION- BLAESE ET AL., CANCER GENE THER., (1995), vol. 2, pages 291 - 297
DESCRIPTION- BLOOD, vol. 88, pages 3901 - 3909
DESCRIPTION- BLUNDELL ET AL., EUR J BIOCHEM, (1988), vol. 172, page 513
DESCRIPTION- BORTOLANZA ET AL., MOLECULAR THERAPY, (201111), vol. 19, no. 11, pages 2055 - 2064
DESCRIPTION- BOSHART ET AL., CELL, (1985), vol. 41, pages 521 - 530
DESCRIPTION- BOSHART ET AL., CELL, (1995), vol. 41, pages 521 - 530
DESCRIPTION- BOUDREAU ET AL., MOLECULAR THERAPY, (200906), vol. 17, no. 6
DESCRIPTION- BOUSSO ET AL., PROC. NATL., ACAD. SCI. USA, (2000), vol. 97, pages 274 - 278
DESCRIPTION- BUCHSCHER ET AL., J. VIROL., (1992), vol. 66, pages 2731 - 2739
DESCRIPTION- BUNTING ET AL., HUM. GENE THER., (2000), vol. 11, pages 2353 - 2364
DESCRIPTION- BUNTING ET AL., NAT. MED., (1998), vol. 4, pages 58 - 64
DESCRIPTION- BYRNE; RUDDLE, PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, pages 5473 - 5477
DESCRIPTION- CALAME; EATON, ADV. IMMUNOL., (1988), vol. 43, pages 235 - 275
DESCRIPTION- CAMPES; TILGHMAN, GENES DEV., (1989), vol. 3, pages 537 - 546
DESCRIPTION- CAMPOCHIARO ET AL., HUMAN GENE THERAPY, (200602), vol. 17, pages 167 - 176
DESCRIPTION- CANDOTTI ET AL., BLOOD, (1996), vol. 87, pages 3097 - 3102
DESCRIPTION- CAVAZZANA-CALVO ET AL., ANNU. REV. MED., (2005), vol. 56, pages 585 - 602
DESCRIPTION- CAVAZZANA-CALVO ET AL., SCIENCE, (2000), vol. 288, pages 669 - 672
DESCRIPTION- CELL, (1993), vol. 73, pages 147 - 157
DESCRIPTION- CHAN-HUI ET AL., CLINICAL IMMUNOLOGY, (2003), vol. 111, pages 162 - 174
DESCRIPTION- CHEN ET AL., GENE THERAPY, (2007), vol. 14, pages 11 - 19
DESCRIPTION- CHO ET AL., "Rapid and Tunable Control of Protein Stability in Caenorhabditis elegans Using a Small Molecule", PLOS ONE, (2013), vol. 8, no. 8, page E72393
DESCRIPTION- CHOI ET AL., PROC. NATL. ACAD. SCI. USA., (2013), vol. 110, no. 19, pages 7625 - 7630
DESCRIPTION- CHUNG H, NATURE CHEMICAL BIOLOGY, (201509), vol. 11, pages 713 - 720
DESCRIPTION- COELHO ET AL., N ENGL J MED, (2013), vol. 369, pages 819 - 29
DESCRIPTION- COHEN ET AL., NAT GENET, (200502), vol. 37, no. 2, pages 161 - 5
DESCRIPTION- CRABTREE ET AL., CHEMISTRY & BIOLOGY, (200601), vol. 13, pages 99 - 107
DESCRIPTION- CRONICAN ET AL., ACS CHEMICAL BIOLOGY, (2010), vol. 5, pages 747 - 752
DESCRIPTION- CRONICAN ET AL., CHEMISTRY & BIOLOGY, (2011), vol. 18, pages 833 - 838
DESCRIPTION- CRYSTAL, SCIENCE, (1995), vol. 270, pages 404 - 410
DESCRIPTION- CUTLER ET AL., J. AM. CHEM. SOC., (2011), vol. 133, pages 9254 - 9257
DESCRIPTION- CUTLER ET AL., J. AM. CHEM. SOC., (2012), vol. 134, pages 1376 - 1391
DESCRIPTION- DAHLMAN ET AL., ORTHOGONAL GENE CONTROL WITH A CATALYTICALLY ACTIVE CAS9 NUCLEASE
DESCRIPTION- DALKARA ET AL., SCI TRANSL MED, (2013), vol. 5, page 189RA76
DESCRIPTION- DAVIS ET AL., NATURE, (20100415), vol. 464
DESCRIPTION- DEVEREUX ET AL., NUC. ACIDS RESEARCH, (1984), vol. 12, page 387
DESCRIPTION- DEVEREUX ET AL., NUCLEIC ACIDS RESEARCH, (1984), vol. 12, page 387
DESCRIPTION- DEY ET AL., PROT SCI, (2013), vol. 22, pages 359 - 66
DESCRIPTION- DIFIGLIA ET AL., PNAS, (20071023), vol. 104, no. 43, pages 17204 - 17209
DESCRIPTION- DIGIUSTO ET AL., SCI TRANSL MED, (2010), vol. 2, page 36RA43
DESCRIPTION- DILLON, TIBTECH, (1993), vol. 11, pages 167 - 175
DESCRIPTION- DONG ET AL., ANTIVIRAL RES., (20150403), pages 110 - 7
DESCRIPTION- DONG ET AL., ANTIVIRAL RES., (20150403), vol. 118, pages 110 - 7
DESCRIPTION- DRAKOPOULOU, "Review Article, The Ongoing Challenge of Hematopoietic Stem Cell-Based Gene Therapy for ?-Thalassemia", STEM CELLS INTERNATIONAL, vol. 2011, page 10
DESCRIPTION- DUMITRACHE ET AL., GENETICS, (201108), vol. 188, no. 4, pages 787 - 797
DESCRIPTION- DUMONCEAUX ET AL., MOLECULAR THERAPY, (201005), vol. 18, no. 5, pages 881 - 887
DESCRIPTION- DUNBRACK ET AL., FOLDING AND DESIGN, (1997), vol. 2, pages 27 - 42
DESCRIPTION- EDLUND ET AL., SCIENCE, (1985), vol. 230, pages 912 - 916
DESCRIPTION- EL-ANDALOUSSI ET AL., NATURE, (2012), vol. 7, pages 2112 - 2126
DESCRIPTION- ESVELT ET AL., CONCERNING RNA-GUIDED GENE DRIVES FOR THE ALTERATION OF WILD POPULATIONS ELIFE, (2014), vol. 3, page E03401
DESCRIPTION- EULALIO ET AL., NATURE, (2012), vol. 492, page 376
DESCRIPTION- FEMS MICROBIOL LETT., (1999), vol. 174, no. 2, pages 247 - 50
DESCRIPTION- FEMS MICROBIOL LETT, (1999), vol. 177, no. 1, pages 187 - 8
DESCRIPTION- FINE ET AL., SCI REP, (20150701), vol. 5, page 10777
DESCRIPTION- FINE ET AL., SCI REP., (20150701), vol. 5, page 10777
DESCRIPTION- FISCHER ET AL., IMMUNOL. REV., (2005), vol. 203, pages 98 - 109
DESCRIPTION- GAO ET AL., GENE THERAPY, (1995), vol. 2, pages 710 - 722
DESCRIPTION- GARRETT, N.L. ET AL., J BIOPHOTONICS, (2012), vol. 5, no. 5-6, pages 458 - 68
DESCRIPTION- GARRETT, N.L. ET AL., J RAMAN SPECT, (2012), vol. 43, no. 5, pages 681 - 688
DESCRIPTION- GASPAR ET AL., LANCET, (2004), vol. 364, pages 2181 - 2187
DESCRIPTION- GEISBERT ET AL., LANCET, (2010), vol. 375, pages 1896 - 905
DESCRIPTION- GHORBAL ET AL., "Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system", NATURE BIOTECHNOLOGY, (20140601), vol. 32, pages 819 - 821
DESCRIPTION- GHORBAL ET AL., "Genome editing in the human malaria parasite Plasmodium falciparumusing the CRISPR-Cas9 system", NATURE BIOTECHNOLOGY, (20140601), vol. 32, pages 819 - 821
DESCRIPTION- GIBLETT ET AL., LANCET, (1972), vol. 2, pages 1067 - 1069
DESCRIPTION- GIULIANO AVANZINI, JEFFREY L. NOEBELS,, Genetics of Epilepsy and Genetic Epilepsies, MARIANI FOUNDATION PAEDIATRIC NEUROLOGY, (2009), vol. 20
DESCRIPTION- GOEDDEL, GENE EXPRESSION TECHNOLOGY: METHODS IN ENZYMOLOGY, ACADEMIC PRESS, (1990), vol. 185
DESCRIPTION- GREER, SCIENCE, (1985), vol. 228, page 1055
DESCRIPTION- GRIMM, D ET AL., J. VIROL., (2008), vol. 82, pages 5887 - 5911
DESCRIPTION- GRIMM ET AL., NATURE, (20060526), vol. 441
DESCRIPTION- GROENEN ET AL., MOL. MICROBIOL., (1993), vol. 10, pages 1057 - 1065
DESCRIPTION- HACEIN-BEY ET AL., BLOOD, (1998), vol. 92, pages 4090 - 4097
DESCRIPTION- HAGSTROM ET AL., MOLECULAR THERAPY, (200408), vol. 10, no. 2
DESCRIPTION- HAO ET AL., SMALL, (2011), vol. 7, pages 3158 - 3162
DESCRIPTION- HARRISON ET AL., GENES & DEVELOPMENT, vol. 28, pages 1859 - 1872
DESCRIPTION- HEO ET AL., STEM CELLS DEV, (20141103), vol. 24, no. 3, pages 393 - 402
DESCRIPTION- HERMONAT; MUZYCZKA, PNAS, (1984), vol. 81, pages 6466 - 6470
DESCRIPTION- HIGGINS DG; SHARP PM, GENE, (1988), vol. 73, no. 1, pages 237 - 244
DESCRIPTION- HIRSCHHORN ET AL., NAT. GENET, (1996), vol. 13, pages 290 - 295
DESCRIPTION- HOE ET AL., EMERG. INFECT. DIS., (1999), vol. 5, pages 254 - 263
DESCRIPTION- HOLT, N. ET AL., NATURE BIOTECHNOLOGY, (2010), vol. 28, pages 839 - 847
DESCRIPTION- HORWELL DC, TRENDS BIOTECHNOL., (1995), vol. 13, no. 4, pages 132 - 134
DESCRIPTION- HUTTER, G. ET AL., THE NEW ENGLAND JOURNAL OF MEDICINE, (2009), vol. 360, pages 692 - 698
DESCRIPTION- ISHINO ET AL., J. BACTERIOL., (1987), vol. 169, pages 5429 - 5433
DESCRIPTION- JANSEN ET AL., MOL. MICROBIOL., (2002), vol. 43, pages 1565 - 1575
DESCRIPTION- JANSSEN ET AL., OMICS J. INTEG. BIOL., (2002), vol. 6, pages 23 - 33
DESCRIPTION- JAYARAMAN, ANGEW. CHEM. INT. ED., (2012), vol. 51, pages 8529 - 8533
DESCRIPTION- JENSEN ET AL., SCI. TRANSL. MED., (2013), vol. 5, page 209RA152
DESCRIPTION- JIANG ET AL., NANO LETT., (20130313), vol. 13, no. 3, pages 1059 - 64
DESCRIPTION- JOHANN ET AL., J. VIROL., (1992), vol. 66, pages 1635 - 1640
DESCRIPTION- JONES ET AL., "San Diego, Calif.: Molecular Simulations", ACTA CRYSTALLOGRAPHY, (1991), vol. A47, pages 110 - 119
DESCRIPTION- JUDGE, J. CLIN. INVEST., (2009), vol. 119, pages 661 - 673
DESCRIPTION- JUNG ET AL., MOLECULAR THERAPY, (201304), vol. 21, no. 4, pages 834 - 841
DESCRIPTION- KARAGIANNIS ET AL., ACS NANO, (20121023), vol. 6, no. 10, pages 8484 - 7
DESCRIPTION- KARIMOVA ET AL., SCI REP., (20150903), vol. 5, page 13734
DESCRIPTION- KAUFMAN ET AL., EMBO J., (1987), vol. 6, pages 187 - 195
DESCRIPTION- KESSEL; GRUSS, SCIENCE, (1990), vol. 249, pages 374 - 379
DESCRIPTION- KINOUCHI ET AL., GENE THERAPY, (2008), vol. 15, pages 1126 - 1130
DESCRIPTION- KONERMANN ET AL., GENOME-SCALE TRANSCRIPTION ACTIVATION BY AN ENGINEERED CRISPR-CAS9 COMPLEX
DESCRIPTION- KONERMANN ET AL., NATURE, (20150129), vol. 517, pages 583 - 588
DESCRIPTION- KONERMANN S; BRIGHAM MD; TREVINO AE; HSU PD; HEIDENREICH M; CONG L; PLATT RJ; SCOTT DA; CHURCH GM; ZHANG F, "Optical control of mammalian endogenous transcription and epigenetic states", NATURE, (20130823), vol. 500, no. 7463, pages 472 - 6
DESCRIPTION- KONNERMAN ET AL., NATURE, (20150129), vol. 517, pages 583 - 588
DESCRIPTION- KOTIN, HUMAN GENE THERAPY, (1994), vol. 5, pages 793 - 801
DESCRIPTION- KREMER; PERRICAUDET, BRITISH MEDICAL BULLETIN, (1995), vol. 51, no. 1, pages 31 - 44
DESCRIPTION- KUIJAN; HERSKOWITZ, CELL, (1982), vol. 30, pages 933 - 943
DESCRIPTION- LALATSA, A. ET AL., J CONTR REL, (2012), vol. 161, no. 2, pages 523 - 36
DESCRIPTION- LALATSA, A. ET AL., MOL PHARM, (2012), vol. 9, no. 6, pages 1665 - 80
DESCRIPTION- LALATSA, A. ET AL., MOL PHARM, (2012), vol. 9, no. 6, pages 1764 - 74
DESCRIPTION- LALATSA ET AL., J CONTROL RELEASE., (20120720), vol. 161, no. 2, pages 523 - 36
DESCRIPTION- LAWRENCE ET AL., JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (2007), vol. 129, pages 10110 - 10112
DESCRIPTION- LEACHMAN ET AL., MOLECULAR THERAPY, (201002), vol. 18, no. 2, pages 442 - 446
DESCRIPTION- LEE ET AL., NAT NANOTECHNOL, (20120603), vol. 7, no. 6, pages 389 - 93
DESCRIPTION- LEE ET AL., PROC NATL ACAD SCI USA., (20140520), vol. 111, no. 20, pages 7260 - 5
DESCRIPTION- LEWIS ET AL., NAT. GEN, (2002), vol. 32, pages 107 - 108
DESCRIPTION- LI ET AL., J GEN VIROL., (20150408), vol. 96, no. 8, pages 2381 - 93
DESCRIPTION- LI ET AL., MOLECULAR THERAPY, (200912), vol. 17, no. 12, pages 2067 - 2077
DESCRIPTION- LI, GENE THERAPY, (2012), vol. 19, pages 775 - 780
DESCRIPTION- LI, L ET AL., MOLECULAR THERAPY : THE JOURNAL OF THE AMERICAN SOCIETY OF GENE THERAPY, (2013), vol. 21, pages 1259 - 1269
DESCRIPTION- LI, L. ET AL., MOLECULAR THERAPY : THE JOURNAL OF THE AMERICAN SOCIETY OF GENE THERAPY, (2013), vol. 21, pages 1259 - 1269
DESCRIPTION- LIN ET AL., MOL THER NUCLEIC ACIDS, (20140819), vol. 3, page EL86
DESCRIPTION- LIN ET AL., MOL THER NUCLEIC ACIDS., (20140819), vol. 3, page EL86
DESCRIPTION- LING ET AL., BMC PLANT BIOLOGY, (2014), vol. 14, page 327
DESCRIPTION- LIN-YANGA ET AL., PNAS, (20090310), vol. 106, no. 10
DESCRIPTION- LIU ET AL., J GEN VIROL., (20150422), vol. 96, no. 8, pages 2252 - 61
DESCRIPTION- LIU, R. ET AL., CELL, (1996), vol. 86, pages 367 - 377
DESCRIPTION- LIVINGSTONE C.D.; BARTON G.J., "Protein sequence alignments: a strategy for the hierarchical analysis of residue conservation", COMPUT. APPL. BIOSCI., (1993), vol. 9, pages 745 - 756
DESCRIPTION- LOMBARDO ET AL., NAT BIOTECHNOL., (200711), vol. 25, no. 11, pages 1298 - 306
DESCRIPTION- LOWDER ET AL., PLANT PHYSIOL., (20150821), page 00636
DESCRIPTION- LUCKLOW; SUMMERS, VIROLOGY, (1989), vol. 170, pages 31 - 39
DESCRIPTION- MA ET AL., MOL PLANT., (20150803), vol. 8, no. 8, pages 1274 - 84
DESCRIPTION- MALI P ET AL., "RNA-Guided Human Genome Engineering via Cas9", SCIENCE, (2013), vol. 339, no. 6121, pages 823 - 826
DESCRIPTION- MANDAL ET AL., CELL STEM CELL, (20141106), vol. 15, no. 5, pages 643 - 652
DESCRIPTION- MASEPOHL ET AL., BIOCHIM. BIOPHYS. ACTA, (1996), vol. 1307, pages 26 - 30
DESCRIPTION- MAYNARD-SMITH LA; CHEN LC; BANASZYNSKI LA; OOI AG; WANDLESS TJ, "A directed approach for engineering conditional protein stability using biologically silent small molecules", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (2007), vol. 282, pages 24866 - 24872
DESCRIPTION- MAZZA ET AL., ACS NANO., (20130226), vol. 7, no. 2, pages 1016 - 26
DESCRIPTION- MAZZA, M. ET AL., ACSNANO, (2013), vol. 7, no. 2, pages 1016 - 1026
DESCRIPTION- MCBRIDE ET AL., MOLECULAR THERAPY, (201112), vol. 19, no. 12, pages 2152 - 2162
DESCRIPTION- MCLVOR EI; POLAK U; NAPIERALA M, "New insights into repeat instability: role of RNA.DNA hybrids", RNA BIOL., (201009), vol. 7, no. 5, pages 551 - 8
DESCRIPTION- MCNAUGHTON ET AL., PROC. NATL. ACAD. SCI. USA, (2009), vol. 106, pages 6111 - 6116
DESCRIPTION- ., METHODS IN ENZYMOLOGY, ACADEMIC PRESS, INC
DESCRIPTION- METHODS IN MOLECULAR BIOLOGY, (20150210), vol. 1284, pages 239 - 255
DESCRIPTION- MILLER ET AL., J. VIROL., (1991), vol. 65, pages 2220 - 2224
DESCRIPTION- MILLER, NATURE, (1992), vol. 357, pages 455 - 460
DESCRIPTION- MILLINGTON-WARD ET AL., MOLECULAR THERAPY, (201104), vol. 19, no. 4, pages 642 - 649
DESCRIPTION- MIRKIN ET AL., SMALL, vol. 10, pages 186 - 192
DESCRIPTION- MIRKIN, NANOMEDICINE, (2012), vol. 7, pages 635 - 638
DESCRIPTION- MITANI; CASKEY, TIBTECH, (1993), vol. 11, pages 162 - 166
DESCRIPTION- MIYAZAKI, J AM CHEM SOC., (20120307), vol. 134, no. 9, pages 3942 - 3945
DESCRIPTION- MOJICA ET AL., MOL. MICROBIOL., (1995), vol. 17, pages 85 - 93
DESCRIPTION- MOJICA ET AL., MOL. MICROBIOL., (2000), vol. 36, pages 244 - 246
DESCRIPTION- MOL. CELL. BIOL., (1988), vol. 8, no. 1, pages 466 - 472
DESCRIPTION- MOLITORIS ET AL., J AM SOC NEPHROL, (2009), vol. 20, pages 1754 - 1764
DESCRIPTION- MORRELL ET AL., "Crop genomics: advances and applications", NAT REV GENET., (20111229), vol. 13, no. 2, pages 85 - 96
DESCRIPTION- MORRELL ET AL., "Crop genomics:advances and applications", NAT REV GENET, (20111229), vol. 13, no. 2, pages 85 - 96
DESCRIPTION- MORRISSEY ET AL., NATURE BIOTECHNOLOGY, (200508), vol. 23, no. 8
DESCRIPTION- MUKHEIJEA ET AL., ANTIOXIDANTS & REDOX SIGNALING, (2010), vol. 13, no. 5
DESCRIPTION- MUSUNURU ET AL., N ENGL J MED., (20101202), vol. 363, no. 23, pages 2220 - 7
DESCRIPTION- MUZYCZKA, J. CLIN. INVEST., (1994), vol. 94, page 1351
DESCRIPTION- NABEL; FEIGNER, TIBTECH, (1993), vol. 11, pages 211 - 217
DESCRIPTION- NAKAGAWA ET AL., NAT. BIOTECHNOL., (2008), vol. 26, pages 101 - 106
DESCRIPTION- NAKATA ET AL., J. BACTERIOL., (1989), vol. 171, pages 3553 - 3556
DESCRIPTION- NAT BIOTECHNOL., (201406), vol. 32, no. 6, pages 551 - 3
DESCRIPTION- NATURE, (1995), vol. 377, pages 65 - 68
DESCRIPTION- NATURE METHODS, (2008), vol. 5
DESCRIPTION- NISHIKOMORI ET AL., BLOOD, (2004), vol. 103, pages 4565 - 4572
DESCRIPTION- NOVOBRANTSEVA, MOLECULAR THERAPY-NUCLEIC ACIDS, (2012), vol. 1, page E4
DESCRIPTION- OKITA ET AL., NATURE, (2007), vol. 448, pages 260 - 262
DESCRIPTION- PA CARR; GM CHURCH, NATURE BIOTECHNOLOGY, (2009), vol. 27, no. 12, pages 1151 - 62
DESCRIPTION- PAULMURUGAN; GAMBHIR, CANCER RES, (20050815), vol. 65, page 7413
DESCRIPTION- PEREZ, E.E. ET AL., NATURE BIOTECHNOLOGY, (2008), vol. 26, pages 808 - 816
DESCRIPTION- P. GOODFORD, J. MED. CHEM, (1985), vol. 28, pages 849 - 57
DESCRIPTION- PINKERT ET AL., GENES DEV., (1987), vol. 1, pages 268 - 277
DESCRIPTION- PLATT, CELL, (2014), vol. 159, no. 2, pages 440 - 455
DESCRIPTION- PLATT ET AL., CELL, (2014), vol. 159, no. 2, pages 440 - 455
DESCRIPTION- PROC. NATL. ACAD. SCI. USA., (1981), vol. 78, no. 3, pages 1527 - 31
DESCRIPTION- QASIM ET AL., "First Clinical Application of Talen Engineered Universal CAR19 T Cells in B-ALL", ASH 57TH ANNUAL MEETING AND EXPOSITION, (201511), URL: https://ash.confex.com/ash/2015/webprogram/Paper81653.html
DESCRIPTION- QI ET AL., GENE THERAPY, (2013), pages 1 - 9
DESCRIPTION- QUEEN; BALTIMORE, CELL, (1983), vol. 33, pages 741 - 748
DESCRIPTION- QU, X., BIOMACROMOLECULES, (2006), vol. 7, no. 12, pages 3452 - 9
DESCRIPTION- REICH ET AL., MOL. VISION, (2003), vol. 9, pages 210 - 216
DESCRIPTION- REICH ET AL., MOL. VISION., (2003), vol. 9, pages 210 - 216
DESCRIPTION- REJALI ET AL., HEAR RES, (200706), vol. 228, no. 1-2, pages 180 - 7
DESCRIPTION- REMY ET AL., BIOCONJUGATE CHEM., (1994), vol. 5, pages 647 - 654
DESCRIPTION- RODRIGUEZ, CHEM BIOL., (20120323), vol. 19, no. 3, pages 391 - 398
DESCRIPTION- ROSIN ET AL., MOLECULAR THERAPY, (201112), vol. 19, no. 12, pages 1286 - 2200
DESCRIPTION- SALT; PLONTKE, DRUG DISCOVERY TODAY, (2005), vol. 10, pages 1299 - 1306
DESCRIPTION- SAMULSKI ET AL., J. VIROL., (1989), vol. 63, pages 03822 - 3828
DESCRIPTION- SCHIFFELERS ET AL., NUCLEIC ACIDS RESEARCH, (2004), vol. 32, no. 19
DESCRIPTION- SCHROEDER, A.; LEVINS, C.; CORTEZ, C.; LANGER, R.; ANDERSON, D., "Lipid-based nanotherapeutics for siRNA delivery", JOURNAL OF INTERNAL MEDICINE, (2010), vol. 267, pages 9 - 21
DESCRIPTION- SCHULTZ ET AL., GENE, (1987), vol. 54, pages 113 - 123
DESCRIPTION- SCHWANK ET AL., CELL STEM CELL, (2013), vol. 13, pages 653 - 58
DESCRIPTION- SEED, NATURE, (1987), vol. 329, page 840
DESCRIPTION- SEMPLE ET AL., NATURE BIOTECHNOLOGY, (201002), vol. 28, no. 2, pages 172 - 177
DESCRIPTION- SHALEM, O.; SANJANA, NE.; HARTENIAN, E.; SHI, X.; SCOTT, DA.; MIKKELSON, T.; HECKL, D.; EBERT, BL.; ROOT, DE; DOENCH, JG., SCIENCE, (20131212), vol. 343, no. 6166, pages 84 - 87
DESCRIPTION- SHEN ET AL., "Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9", MBIO, (2014), vol. 5, pages E01114 - 14
DESCRIPTION- SHEN ET AL., FEBS LET., (2003), vol. 539, pages 111 - 114
DESCRIPTION- SHIMIZU ET AL., J AM SOC NEPHROL, (2010), vol. 21, pages 622 - 633
DESCRIPTION- SIDIK ET AL., "Efficient Genome Engineering of Toxoplasma gondii Using CRISPR/Cas9", PLOS ONE, (20140627), vol. 9, page EL00450
DESCRIPTION- SIEW, A. ET AL., MOL PHARM, (2012), vol. 9, no. L, pages 14 - 28
DESCRIPTION- SIMEONI ET AL., NAR, (2003), vol. 31, no. 11, pages 2717 - 2724
DESCRIPTION- SIMON RJ ET AL., PNAS, (1992), vol. 89, no. 20, pages 9367 - 9371
DESCRIPTION- SMITH ET AL., MOL. CELL. BIOL., (1983), vol. 3, pages 2156 - 2165
DESCRIPTION- SMITH; JOHNSON, GENE, (1988), vol. 67, pages 31 - 40
DESCRIPTION- SOMASUNTHARAM ET AL., BIOMATERIALS, (2013), vol. 34, page 7790
DESCRIPTION- SOMMNERFELT ET AL., VIROL., (1990), vol. 176, pages 58 - 59
DESCRIPTION- SONG ET AL., STEM CELLS DEV, (20150205), vol. 24, no. 9, pages 1053 - 65
DESCRIPTION- SORENSEN ET AL., J. MOL. BIOL., (2003), vol. 327, pages 761 - 766
DESCRIPTION- SOUDAIS ET AL., BLOOD, (2000), vol. 95, pages 3071 - 3077
DESCRIPTION- SPUCH; NAVARRO, JOURNAL OF DRUG DELIVERY, (2011), vol. 2011, page 12
DESCRIPTION- STEPHAN ET AL., N. ENGL. J. MED., (1996), vol. 335, pages 1563 - 1567
DESCRIPTION- STILES ET AL., EXPERIMENTAL NEUROLOGY, (2012), vol. 233, pages 463 - 471
DESCRIPTION- STUDIER ET AL., GENE EXPRESSION TECHNOLOGY: METHODS IN ENZYMOLOGY, ACADEMIC PRESS, (1990), vol. 185, pages 60 - 89
DESCRIPTION- SUGANO ET AL., PLANT CELL PHYSIOL., (20140118), vol. 55, no. 3, pages 475 - 81
DESCRIPTION- TABERNERO ET AL., CANCER DISCOVERY, (201304), vol. 3, no. 4, pages 363 - 470
DESCRIPTION- TAKAHASHI ET AL., CELL, (2007), vol. 131, no. 5, pages 861 - 872
DESCRIPTION- TAKAHASHI; YAMANAKA, CELL, (2006), vol. 126, pages 663 - 76
DESCRIPTION- TAN ET AL., PROC NATL ACAD SCI USA., (20131008), vol. 110, no. 41, pages 16526 - 16531
DESCRIPTION- TAYLOR ET AL., BLOOD, (1996), vol. 87, pages 3103 - 3107
DESCRIPTION- TEBAS ET AL., N ENGL J MED., (20140306), vol. 370, no. 10, pages 901 - 10
DESCRIPTION- TEBAS, P. ET AL., THE NEW ENGLAND JOURNAL OF MEDICINE, (2014), vol. 370, pages 901 - 910
DESCRIPTION- THE CCP4 SUITE: PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY, ACTA CRYSTALLOGRAPHICA, (1994), vol. D50, pages 760 - 763
DESCRIPTION- THOMPSON, D.B. ET AL., CHEMISTRY & BIOLOGY, (2012), vol. 19, no. 7, pages 831 - 843
DESCRIPTION- THOMPSON ET AL., METHODS IN ENZYMOLOGY, (2012), vol. 503, pages 293 - 319
DESCRIPTION- THOMPSON ET AL., NUCLEIC ACID THERAPEUTICS, (2012), vol. 22, no. 4
DESCRIPTION- TOLENTINO ET AL., RETINA, vol. 24, no. 4, page 660
DESCRIPTION- TRATSCHIN ET AL., MOL. CELL. BIOL, (1984), vol. 4, pages 2072 - 2081
DESCRIPTION- TRATSCHIN ET AL., MOL. CELL. BIOL., (1985), vol. 5, pages 3251 - 3260
DESCRIPTION- TSAI ET AL., BLOOD, (2002), vol. 100, pages 72 - 79
DESCRIPTION- TSAI ET AL., "Dimeric CRISPR RNA-guided Fokl nucleases for highly specific genome editing", NATURE BIOTECHNOLOGY, (2014), vol. 32, no. 6, pages 569 - 77, XP055378307
DESCRIPTION- TSAI ET AL., NATURE BIOTECHNOLOGY, (201406), vol. 32, no. 6
DESCRIPTION- UCHEGBU, I.F. ET AL., INT J PHARM, (2001), vol. 224, pages 185 - 199
DESCRIPTION- UCHEGBU, I.F., EXPERT OPIN DRUG DELIV, (2006), vol. 3, no. 5, pages 629 - 40
DESCRIPTION- UCHEGBU; SIEW, J PHARM SCI., (2013), vol. 102, no. 2, pages 305 - 10
DESCRIPTION- UNO ET AL., HUMAN GENE THERAPY, (201106), vol. 22, pages 711 - 719
DESCRIPTION- VAN BRUNT, BIOTECHNOLOGY, (1988), vol. 6, no. 10, pages 1149 - 1154
DESCRIPTION- VAN EMBDEN ET AL., J. BACTERIOL., (2000), vol. 182, pages 2393 - 2401
DESCRIPTION- VIGNE, RESTORATIVE NEUROLOGY AND NEUROSCIENCE, (1995), vol. 8, pages 35 - 36
DESCRIPTION- VYAS ET AL., "A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families", SCIENCE ADVANCES, (20150403), vol. 1, page E1500248
DESCRIPTION- WADA ET AL., PROC. NATL. ACAD. SCI. USA, (2001), vol. 98, pages 8697 - 8702
DESCRIPTION- WAHLGREN ET AL., NUCLEIC ACIDS RESEARCH, (2012), vol. 40, no. 17, page E130
DESCRIPTION- WALTERS ET AL., DRUG DISCOVERY TODAY, (1998), vol. 3, no. 4, pages 160 - 178
DESCRIPTION- WANG ET AL., PLOS ONE., (20141226), vol. 9, no. 12, page 15987
DESCRIPTION- WANG ET AL., PLOS ONE, (20141226), vol. 9, no. 12, page EL 15987
DESCRIPTION- WANG ET AL., WORLD J GASTROENTEROL., (20150828), vol. 21, no. 32, pages 9554 - 65
DESCRIPTION- WATTS, "Hematopoietic Stem Cell Expansion and Gene Therapy", CYTOTHERAPY, (2011), vol. 13, no. 10, pages 1164 - 1171
DESCRIPTION- WEINTRAUB, NATURE, (2013), vol. 495, pages S14 - S16
DESCRIPTION- WEST ET AL., VIROLOGY, (1987), vol. 160, pages 38 - 47
DESCRIPTION- WHITEHEAD ET AL., ACS NANO., (20120828), vol. 6, no. 8, pages 6922 - 9
DESCRIPTION- WILLIAMS, "Broadening the Indications for Hematopoietic Stem Cell Genetic Therapies", CELL STEM CELL, (2013), vol. 13, pages 263 - 264
DESCRIPTION- WILSON ET AL., J. VIROL., (1989), vol. 63, pages 2374 - 2378
DESCRIPTION- WINOTO; BALTIMORE, EMBO J., (1989), vol. 8, pages 729 - 733
DESCRIPTION- WOODDELL ET AL., MOLECULAR THERAPY, (201305), vol. 21, no. 5, pages 973 - 985
DESCRIPTION- WU, CELL STEM CELL, (2013), vol. 13, pages 659 - 62
DESCRIPTION- XIA ET AL., NAT. BIOTECH, (2002), vol. 20, pages 1006 - 1010
DESCRIPTION- XIA ET AL., NAT. BIOTECH., (2002), vol. 20, pages 1006 - 1010
DESCRIPTION- XU ET AL., SCIENCE, (20111118), vol. 334, no. 6058, pages 993 - 996
DESCRIPTION- XU ET AL., SCI REP., (20150709), vol. 5, page 12065
DESCRIPTION- XU, "Gene targeting using the Agrobacterium tumefaciens-mediated CRISPR-Cas system in rice", RICE, (2014), vol. 7, page 5
DESCRIPTION- YATES ET AL., BLOOD, (2002), vol. 100, pages 3942 - 3949
DESCRIPTION- YOUNG ET AL., NANO LETT., (2012), vol. 12, pages 3867 - 71
DESCRIPTION- YUAN ET AL., AM J PHYSIOL RENAL PHYSIOL, (2008), vol. 295, pages F605 - F617
DESCRIPTION- YU ET AL., CELL, (20120831), vol. 150, pages 895 - 908
DESCRIPTION- YU ET AL., GENE THERAPY, (1994), vol. 1, pages 13 - 26
DESCRIPTION- YU, J. ET AL., SCIENCE, (2007), vol. 318, no. 5858, pages 1917 - 1920
DESCRIPTION- ZAEHRES; SCHOLER, CELL, (2007), vol. 131, no. 5, pages 834 - 835
DESCRIPTION- ZAMORA ET AL., AM J RESPIR CRIT CARE MED, (2011), vol. 183, pages 531 - 538
DESCRIPTION- ZHANG C. ET AL., "Efficient editing of malaria parasite genome using the CRISPR/Cas9 system", MBIO, (20140701), vol. 5, no. 4, pages E01414 - 14
DESCRIPTION- ZHANG ET AL., ACS NANO., (2011), vol. 5, pages 6962 - 6970
DESCRIPTION- ZHANG ET AL., ADV MATER., (20130906), vol. 25, no. 33, pages 4641 - 5
DESCRIPTION- ZHANG ET AL., "Efficient Editing of Malaria Parasite Genome Using the CRISPR/Cas9 System", MBIO, (201407), vol. 5, pages E01414 - 14
DESCRIPTION- ZHANG ET AL., J. AM. CHEM. SOC., (2012), vol. 134, pages 16488 - 1691
DESCRIPTION- ZHANG ET AL., NATURE, (2012), vol. 490, no. 7421, pages 556 - 60
DESCRIPTION- ZHAO ET AL., NAT GENET, (2006), vol. 38, pages 1341 - 7
DESCRIPTION- ZHENG ET AL., PNAS, (20120724), vol. 109, no. 30, pages 11975 - 11980
DESCRIPTION- ZHENG ET AL., PROC. NATL. ACAD. SCI. USA., (2012), vol. 109, pages 11975 - 80
DESCRIPTION- ZHOU ET AL., "Exploiting SNPs for biallelic CRISPR mutations in the outcrossing woody perennial Populus reveals 4-coumarate: CoA ligase specificity and Redundancy", NEW PHYTOLOGIST, (2015), pages 1 - 4
DESCRIPTION- ZHOU ET AL., NEW PHYTOLOGIST, (201510), vol. 208, no. 2, pages 298 - 301
DESCRIPTION- ZIMMERMAN ET AL., NATURE LETTERS, (20060504), vol. 441
DESCRIPTION- ZOU ET AL., HUMAN GENE THERAPY, (201104), vol. 22, pages 465 - 475
DESCRIPTION- ZUKER; STIEGLER, NUCLEIC ACIDS RES., (1981), vol. 9, pages 133 - 148
DESCRIPTION- CHO, S.; GOLDBERG, M.; SON, S.; XU, Q.; YANG, F.; MEI, Y.; BOGATYREV, S.; LANGER, R.; ANDERSON, D., "Lipid-like nanoparticles for small interfering RNA delivery to endothelial cells", ADVANCED FUNCTIONAL MATERIALS, (2010), vol. 19, doi:doi:10.1002/adfm.200900519, pages 3112 - 3118, XP001548633
DESCRIPTION- BANASZYNSKI LA; CHEN LC; MAYNARD-SMITH LA; OOI AG; WANDLESS TJ, "A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules", CELL, (2006), vol. 126, doi:doi:10.1016/j.cell.2006.07.025, pages 995 - 1004, XP008119027
DESCRIPTION- WANG H.; YANG H.; SHIVALILA CS.; DAWLATY MM.; CHENG AW.; ZHANG F.; JAENISCH R, "One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering", CELL, (20130509), vol. 153, no. 4, doi:doi:10.1016/j.cell.2013.04.025, pages 910 - 8, XP028538358
DESCRIPTION- NISHIMASU ET AL., "Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA", CELL, (2014), vol. 156, no. 5, doi:doi:10.1016/j.cell.2014.02.001, pages 935 - 949, XP028667665
DESCRIPTION- NISHIMASU, H.; RAN, FA; HSU, PD.; KONERMANN, S.; SHEHATA, SI; DOHMAE, N.; ISHITANI, R.; ZHANG, F.; NUREKI, O., "Crystal structure of cas9 in complex with guide RNA and target DNA", CELL, (20140227), vol. 156, no. 5, doi:doi:10.1016/j.cell.2014.02.001, pages 935 - 49, XP028667665
DESCRIPTION- HSU ET AL., "Development and Applications of CRISPR-Cas9 for Genome Engineering", CELL, (20140605), vol. 157, doi:doi:10.1016/j.cell.2014.05.010, pages 1262 - 1278, XP028849523
DESCRIPTION- PLATT ET AL., "CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling", CELL, (2014), vol. 159, no. 2, doi:doi:10.1016/j.cell.2014.09.014, pages 440 - 455, XP029073412
DESCRIPTION- CHEN S; SANJANA NE; ZHENG K; SHALEM O; LEE K; SHI X; SCOTT DA; SONG J; PAN JQ; WEISSLEDER R, "Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis", CELL, (20150312), vol. 160, doi:doi:10.1016/j.cell.2015.02.038, pages 1246 - 1260, XP029203797
DESCRIPTION- PARNAS ET AL., "A Genome-wide CRISPR Screen in Primary Immune Cells to Dissect Regulatory Networks", CELL, (20150730), vol. 162, doi:doi:10.1016/j.cell.2015.06.059, pages 675 - 686, XP029248090
DESCRIPTION- NISHIMASU ET AL., "Crystal Structure of Staphylococcus aureus Cas9", CELL, (20150827), vol. 162, doi:doi:10.1016/j.cell.2015.08.007, pages 1113 - 1126, XP055304450
DESCRIPTION- ZETSCHE ET AL., "Cpfl Is ? Single RNA-Guided Endonuclease of ? Class 2 CRISPR-Cas System", CELL, (20150925), vol. 163, doi:doi:10.1016/j.cell.2015.09.038, pages 759 - 71, XP055267511
DESCRIPTION- SHMAKOV ET AL., "Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems", MOLECULAR CELL, (20151022), vol. 60, no. 3, doi:doi:10.1016/j.molcel.2015.10.008, pages 385 - 397, XP055481389
DESCRIPTION- KIEM, "Hematopoietic stem cell-based gene therapy for HIV disease", CELL STEM CELL, (20120203), vol. 10, no. 2, doi:doi:10.1016/j.stem.2011.12.015, pages 137 - 147, XP002731081
DESCRIPTION- MANDAL ET AL., "Efficient Ablation of Genes in Human Hematopoietic Stem and Effector Cells using CRISPR/Cas9", CELL STEM CELL, (20141106), vol. 15, no. 5, doi:doi:10.1016/j.stem.2014.10.004, pages 643 - 652, XP055348680
DESCRIPTION- TAYLOR W.R., "The classification of amino acid conservation", J. THEOR. BIOL., (1986), vol. 119, doi:doi:10.1016/S0022-5193(86)80075-3, pages 205 - 218, XP055050432
DESCRIPTION- SU X; FRICKE J; KAVANAGH DG; IRVINE DJ, "In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles", MOL PHARM., (20110401), vol. 8, no. 3, doi:doi:10.1021/mp100390w, pages 774 - 87, XP055127583
DESCRIPTION- FENG, "Efficient genome editing in plants using a CRISPR/Cas system", CELL RESEARCH, (20130820), vol. 23, doi:doi:10.1038/cr.2013.114, pages 1229 - 1232, XP055153531
DESCRIPTION- CAVAZZANA-CALVO, "Transfusion independence and HMGA2 activation after gene therapy of human ?-thalassaemia", NATURE, (20100916), vol. 467, doi:doi:10.1038/nature09328, pages 318 - 322, XP055258772
DESCRIPTION- KONERMANN S; BRIGHAM MD; TREVINO AE; JOUNG J; ABUDAYYEH 00; BARCENA C; HSU PD; HABIB N; GOOTENBERG JS; NISHIMASU H, "Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex", NATURE, (20150129), vol. 517, no. 7536, doi:doi:10.1038/nature14136, pages 583 - 8, XP055206834
DESCRIPTION- RAN FA; CONG L; YAN WX; SCOTT DA; GOOTENBERG JS; KRIZ AJ; ZETSCHE B; SHALEM O; WU X; MAKAROVA KS, "In vivo genome editing using Staphylococcus aureus Cas9", NATURE, (20150401), vol. 520, no. 7546, doi:doi:10.1038/nature14299, pages 186 - 91, XP055484527
DESCRIPTION- CANVER ET AL., "BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis", NATURE, (20150916), vol. 527, no. 7577, doi:doi:10.1038/nature15521, pages 192 - 7, XP055274680
DESCRIPTION- MICHAEL S D KORMANN ET AL., "Expression of therapeutic proteins after delivery of chemically modified mRNA in mice", NATURE BIOTECHNOLOGY, (2011), vol. 29, doi:doi:10.1038/nbt.1733, pages 154 - 157, XP002696192
DESCRIPTION- JIANG ET AL., "RNA-guided editing of bacterial genomes using CRISPR-Cas systems", NATURE BIOTECHNOLOGY, (201303), vol. 31, doi:doi:10.1038/nbt.2508, pages 233 - 9, XP055249123
DESCRIPTION- JIANG W.; BIKARD D.; COX D.; ZHANG F; MARRAFFINI LA, "RNA-guided editing of bacterial genomes using CRISPR-Cas systems", NAT BIOTECHNOL, (201303), vol. 31, no. 3, doi:doi:10.1038/nbt.2508, pages 233 - 9, XP055249123
DESCRIPTION- SHAN, "Targeted genome modification of crop plants using a CRISPR-Cas system", NATURE BIOTECHNOLOGY, (2013), vol. 31, doi:doi:10.1038/nbt.2650, pages 686 - 688, XP055216828
DESCRIPTION- FU ET AL., "Improving CRISPR-Cas nuclease specificity using truncated guide RNAs", NATURE BIOTECHNOLOGY, (20131117), vol. 32, doi:doi:10.1038/nbt.2808, pages 279 - 284, XP055259718
DESCRIPTION- BIKARD ET AL., "Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials", NATURE BIOTECHNOLOGY, (20141005), vol. 32, doi:doi:10.1038/nbt.3043, pages 1146 - 1150, XP002742966
DESCRIPTION- ZETSCHE B; VOLZ SE; ZHANG F., "A split-Cas9 architecture for inducible genome editing and transcription modulation", NAT BIOTECHNOL., (20150202), vol. 33, no. 2, doi:doi:10.1038/nbt.3149, pages 139 - 42, XP055227889
DESCRIPTION- ZETSCHE ET AL., "A split-Cas9 architecture for inducible genome editing and transcription modulation", NATURE BIOTECHNOLOGY, (20150202), vol. 33, doi:doi:10.1038/nbt.3149, pages 139 - 142, XP055227889
DESCRIPTION- CALIANDO ET AL., "Targeted DNA degradation using a CRISPR device stably carried in the host genome", NATURE COMMUNICATIONS, vol. 6, doi:doi:10.1038/ncomms7989, page 6989, XP055311048
DESCRIPTION- WAGNER ET AL., "Efficient CRISPR-Cas9-mediated genome editing in Plasmodium falciparum", NATURE METHODS, (2014), vol. 11, doi:doi:10.1038/nmeth.3063, pages 915 - 918, XP055336954
DESCRIPTION- EL-ANDALOUSSI S ET AL., "Exosome-mediated delivery of siRNA in vitro and in vivo", NAT PROTOC, (20121115), vol. 7, no. 12, doi:doi:10.1038/nprot.2012.131, pages 2112 - 26, XP055129954
DESCRIPTION- RAN, FA.; HSU, PD.; WRIGHT, J.; AGARWALA, V.; SCOTT, DA.; ZHANG, F, "Genome engineering using the CRISPR-Cas9 system.", NATURE PROTOCOLS, (201311), vol. 8, no. 11, doi:doi:10.1038/nprot.2013.143, pages 2281 - 308, XP009174668
DESCRIPTION- SHALEM ET AL., "High-throughput functional genomics using CRISPR-Cas9,", NATURE REVIEWS GENETICS, (201505), vol. 16, doi:doi:10.1038/nrg3899, pages 299 - 311, XP055207968
DESCRIPTION- RAMANAN ET AL., "CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus", SCIENTIFIC REPORTS, (20150602), vol. 5, doi:doi:10.1038/srep10833, page 10833, XP055305966
DESCRIPTION- YOUSEF ET AL., "Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria", PROC. NATL. ACAD. SCI. USA, (20150518), vol. 112, doi:doi:10.1073/pnas.1500107112, pages 7267 - 7272, XP002742965
DESCRIPTION- XIE, "RNA-guided genome editing in plants using a CRISPR-Cas system", MOL PLANT., (20130817), vol. 6, no. 6, doi:doi:10.1093/mp/sst119, pages 1975 - 83, XP055154141
DESCRIPTION- XIE, "RNA-guided genome editing in plants using a CRISPR-Cas system", MOL PLANT., (201311), vol. 6, no. 6, doi:doi:10.1093/mp/sst119, pages 1975 - 83, XP055154141
DESCRIPTION- NAKAMURA, Y. ET AL., "Codon usage tabulated from the international DNA sequence databases: status for the year 2000", NUCL. ACIDS RES, (2000), vol. 28, doi:doi:10.1093/nar/28.1.292, page 292, XP002941557
DESCRIPTION- NAKAMURA, Y. ET AL., "Codon usage tabulated from the international DNA sequence databases: status for the year 2000", NUCL. ACIDS RES., (2000), vol. 28, doi:doi:10.1093/nar/28.1.292, page 292, XP002941557
DESCRIPTION- XU ET AL., "Sequence determinants of improved CRISPR sgRNA design", GENOME RESEARCH, (201508), vol. 25, doi:doi:10.1101/gr.191452.115, pages 1147 - 1157, XP055321186
DESCRIPTION- CONG, L.; RAN, F.A; COX, D.; LIN, S.; BARRETTO, R.; HABIB, N.; HSU, P.D.; WU, X.; JIANG, W.; MARRAFFINI, L.A., "Multiplex genome engineering using CRISPR/Cas systems", SCIENCE, (20130215), vol. 339, no. 6121, doi:doi:10.1126/science.1231143, pages 819 - 23, XP055469277
DESCRIPTION- WANG ET AL., "Genetic screens in human cells using the CRISPR/Cas9 system", SCIENCE, (20140103), vol. 343, no. 6166, doi:doi:10.1126/science.1246981, pages 80 - 84, XP055294787
DESCRIPTION- NEKRASOV, "Plant genome editing made easy: targeted mutagenesis in model and crop plants using the CRISPR/Cas system", PLANT METHODS, (2013), vol. 9, doi:doi:10.1186/1746-4811-9-39, page 39, XP021164954
EXAMINATION- IWAMOTO M ET AL, "A General Chemical Method to Regulate Protein Stability in the Mammalian Central Nervous System", CHEMISTRY AND BIOLOGY, CURRENT BIOLOGY, LONDON, GB, vol. 17, no. 9, ISSN 1074-5521, (20100924), pages 981 - 988, (20100923), XP027299452
EXAMINATION- Yusuke Miyazaki ET AL, "Destabilizing Domains Derived from the Human Estrogen Receptor", Journal of the American Chemical Society, US, (20120307), vol. 134, no. 9, doi:10.1021/ja209933r, ISSN 0002-7863, pages 3942 - 3945, XP055387238
INTERNATIONAL-SEARCH-REPORT- BALBOA DIEGO ET AL, "Conditionally Stabilized dCas9 Activator for Controlling Gene Expression in Human Cell Reprogramming and Differentiation. (plus Supplemental Information)", STEM CELL REPORTS, (20150908), vol. 5, no. 3, doi:10.1016/j.stemcr.2015.08.001, ISSN 2213-6711, pages 448 - 459+16PP, XP002756302 [XP] 1,18 * the whole document *
INTERNATIONAL-SEARCH-REPORT- J. M. GEISINGER ET AL.,, "In vivo blunt-end cloning through CRISPR/CAS9-facilitated non-homologous end-joining", NUCLEIC ACID RESEARCH ADVANCE ACCESS PUBLISHED JANUARY 13, 2016, (20160113), pages 1 - 15, XP002756304 [T] * the whole document *
INTERNATIONAL-SEARCH-REPORT- S. Senturk et al.,, "A rapid and tunable method to temporally control cas9 expression enables the identification of essential genes and the interrogtion of functional gene interactions in vitro and in vivo", doi:10.1101/023366, (20150728), pages 1 - 27, URL: http://biorxiv.org/content/early/2015/07/28/023366, (20160411), XP002756303 [XP] 1,2,9,25-31,33-43 * the whole document *
INTERNATIONAL-SEARCH-REPORT- HARRISON MELISSA M ET AL, "A CRISPR view of development.", GENES & DEVELOPMENT, (20140901), vol. 28, no. 17, ISSN 1549-5477, pages 1859 - 1872, XP002756301 [A] 1-43 * page 1864, column r, line 41 - line 45 *
OPPOSITION- Assignment of Zetsche to Broad
OPPOSITION- Assignment of Zhang to Broad and MIT
OPPOSITION- BALBOA et al., "Conditionally Stabilized dCas9 Activator for Controlling Gene Expression in Human Cell Reprogramming and Differentiation", Stem Cell Reports, (20150908), vol. 5, doi:10.1016/j.stemcr.2015.08.001, pages 448 - 459
OPPOSITION- Chu et al., "Recent Progress with FKBP-Derived Destabilizing Domains",Bioorg Med Chem Lett., 18(22), 5941 -5944 (2008), plus supplementary material (15.11.2008)
OPPOSITION- Chylinski et al., "The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems", RNA Biology,10(5), 726-737, plus Supplementary Material (05.04.2013)
OPPOSITION- copy of the PCT Request form in respect of the International patent application PCT/US2015/067177
OPPOSITION- Declaration from Ellen Law
OPPOSITION- Dohmen et al., "Heat-inducible degron: a method for constructing temperature-sensitive mutants", Science, 263(5151), 1273-1276,(04.03.1994)
OPPOSITION- extract from the Public PAIR database of the US Patent and Trademark Office (“USPTO”) in respect of the International patent application PCT/US2015/067177
OPPOSITION- Harvard University's Intellectual Property Policy
OPPOSITION- Hoffmann et al. “Detailed comparison of retroviral vectors and promoter configurations for stable and high transgene expression in human induced pluripotent stem cells", Gene Therapy 24: 298-307 (20.04.2017)
OPPOSITION- Hsu et al. “DNA targeting specificity of RNA-guided Cas9 nucleases”,Nature Biotechnology 31(9): 827-832 (21.07.2013)
OPPOSITION- Iwamoto et al. "A General Chemical Method to Regulate Protein Stability in the Mammalian Central Nervous System”, Chemistry & Biology 17: 981-988 (24.09.2010)
OPPOSITION- Kanemaki (2012) Frontiers of protein expression control with conditional degrons, Pflugers Arch Eur J Physiol. 465:419-425
OPPOSITION- Maji et al., 2017 Multidimensional chemical control of CRISPR-Cas9, Nat Chem Biol. Jan; 13(1):9-11
OPPOSITION- MIT Intellectual Property Policy
OPPOSITION- Miyazaki et al. “Destabilizing Domains Derived from the Human Estrogen Receptor”, Journal of the American Chemical Society 134(9): 3942-3945(14.02.2012)
OPPOSITION- Nishimasu et al. “Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA", Cell 156: 935-949 (27,02.2014)
OPPOSITION- printout of an extract from the UniProt database entry for the E. coli dihydrofolate reductase (“DHFR") protein
OPPOSITION- printout of an extract from the UniProt database entry for the human estrogen receptor
OPPOSITION- print out of the online Addgene catalogue entry for the E. coli DHFR-containing plasmid “pBMN DHFR(DD)-YFP”
OPPOSITION- Pruett-Miller et al. “Attenuation of Zinc Finger Nuclease Toxicity by Small-Molecule Regulation of Protein Levels”, PLoS Genetics 5(2): e 1000376.(13.02.2009)
OPPOSITION- Ran et al., "In vivo genome editing using Staphylococcus aureus Cas9",Nature, 520, 186-191, plus supplementary material (01.04.2015)
OPPOSITION- SCHOEBER et al., "Conditional fast expression and function of multimeric TRPV5 channels using Shield- 1", Am J Physiol., (20081008), vol. 296, pages F204 - F211, XP055754877
OPPOSITION- Schoeber et al., "Conditional fast expression and function of multimericTRPV5 channels using Shield 1", Am J Physiol., 296, F204-F211(08.10.2008)
OPPOSITION- Search strategy and results from sequence alignment of "HD2" with Cas9from various organisms
OPPOSITION- Society of Fellows of Harvard University extract
OPPOSITION- The Broad Institute Intellectual Property and Proprietary Information Agreement for Bernd Zetsche
OPPOSITION- Voon DC et al. (2005) Use of mRNA- and protein- destabilizing elements to develop a highly responsive reporter system. Nucleic Acids Research.33(3):e27
OPPOSITION- Wu et al. “Target specificity of the CRISPR-Cas9 system”, Quantitative Biology 2(2 ):59-70 (06.08.2014)
OPPOSITION- CH U et al., "Recent Progress with FKBP-Derived Destabilizing Domains", Bioorg Med Chem Lett., (20081115), vol. 18, no. 22, doi:10.1016/j.bmcl.2008.09.043, pages 5941 - 5944, XP025627175
OPPOSITION- NISHIMASU et al., "Crystal Structure of Cas9 in Complex 27 February with Guide RNA and Target DNA", Cell, (20140227), vol. 156, pages 935 - 949, XP028622533
OPPOSITION- IWAMOTO et al., "A General Chemical Method to Regulate Protein Stability in the Mammalian Central Nervous System", Chemistry & Biology, (20100924), vol. 17, doi:10.1016/j.chembiol.2010.07.009, pages 981 - 988, XP055552908
OPPOSITION- BALBOA et al., "Conditionally Stabilized dCas9 Activator for Controlling Gene Expression in Human Cell Reprogramming and Differentiation", Stem Cell Reports, (20150908), vol. 5, doi:10.1016/j.stemcr.2015.08.001, pages 448 - 459, XP002756302
OPPOSITION- MIYAZAKI et al., "Destabilizing Domains Derived from the Human Estrogen Receptor", J Am Chem Soc., (20120307), vol. 134, no. 9, doi:10.1021/ja209933r, pages 3942 - 3945, XP055387238
OPPOSITION- RAN et al., "In vivo genome editing using Staphylococcus aureus Cas9", Nature, (20150401), vol. 520, doi:10.1038/nature14299, pages 186 - 191, XP055484527
OPPOSITION- SENTURK et al., "A rapid and tunable method to temporally control Cas9 expression enables the identification of essential genes and the interrogation of functional gene interactions in vitro and in vivo", BioRxiv 023366, (20150708), XP002756303
OPPOSITION- DOHMEN et al., "Heat-inducible degron: a method for constructing temperature-sensitive mutants", Science, (19940304), vol. 263, no. 5151, doi:10.1126/science.8122109, pages 1273 - 1276, XP002742294
OPPOSITION- CHYLINSKI et al., "The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems", RNA Biology, (20130405), vol. 10, no. 5, doi:10.4161/rna.24321, pages 726 - 737, XP055116068

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents